NCT07273682Not yet recruiting
Nurse-led Transitional Care to Improve Symptom Management in Childhood Cancer Survivors
A Nurse-facilitated Interdisciplinary Transitional Care Programme for Childhood Cancer Survivors and Their Parents to Improve Symptom Management: a Feasibility Randomised Waitlist-controlled Trial
Source: ClinicalTrials.gov · Last updated 9 Dec 2025
Brief summary (registry, in English)
This study aims to evaluate the feasibility and preliminary effectiveness of a nurse-facilitated interdisciplinary transitional care programme, based on the Omaha system, for Chinese childhood cancer survivors (CCSs) and their parents in Hong Kong. Investigators will conduct a two-arm, randomized waitlist-controlled trial at the Hong Kong Children's Hospital, the only local center for CCS follow-up. Sixty-eight dyads (CCS aged 13-18 and a parent) will be randomized to either the 12-week nurse-led intervention or usual care. The intervention includes an initial face-to-face assessment and regular follow-ups via Zoom, focusing on symptom management, health education, and self-care empowerment, with referrals to other professionals as needed. The control group receives standard discharge care and educational materials, and will be offered the intervention after data collection. Outcomes will be assessed at baseline, and 3 and 6 months post-intervention, including symptom management, quality of life, caregiver burden, self-efficacy, and emergency department visits. Feasibility will be evaluated by recruitment, retention, attendance, and data completeness rates. If effective, this programme could improve transitional care and symptom management for CCSs and their families, and inform clinical practice and policy in Hong Kong and beyond.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- First submitted
- 19 Nov 2025
- Start date
- 1 Jul 2026
- Primary completion date
- 30 Jun 2028
- Lead sponsor
- The Hong Kong Polytechnic University
- Diseases
- Childhood cancers
- NCT number
- NCT07273682
What you commit to
- Study type: Interventional
- Planned participants: 68
- From 1 Jul 2026 to the primary completion date, 30 Jun 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- cognitive impairment
- have terminal cancer
Other
- social and/or behavioural problem
- participate in any similar intervention
- severe emotional problems
- participate in any similar intervention
Who the study is looking for
- aged between 13 and 18 years
- diagnosed with any cancer
- completion of active cancer treatment within a month
- communicate in Chinese
- mother or father who has a significant caregiving role in the child's life
- could participate in the intervention at the same time as their child
- communicate in Chinese
- have an electronic device to access zoom
Age in the registry: 13 years to 18 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.